Yibo Xue

10PUBLICATIONS
63CO-AUTHORS
Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 15, 2026
SMARCA4 loss reprograms p300 chromatin occupancy to subvert p53-mediated transcriptional repression in ovarian small cell carcinoma.

|May 14, 2025
SMARCA4 Loss Increases RNA Polymerase II Pausing and Elevates R-Loops to Inhibit BRCA1-Mediated Repair in Ovarian Cancer.

Xianbing Zhu, Zheng Fu, Giulio Aceto

|Jan 26, 2024
Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer.

Xianbing Zhu, Zheng Fu, Kendall Dutchak

|Jun 14, 2023
A mitotic glue for shattered chromosomes.

Yibo Xue, Daniel Durocher

|Mar 22, 2023
Author Correction: SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria.

Yibo Xue, Jordan L Morris, Kangning Yang

|Feb 05, 2022
The CIP2A-TOPBP1 axis safeguards chromosome stability and is a synthetic lethal target for BRCA-mutated cancer.

Salomé Adam, Silvia Emma Rossi, Nathalie Moatti

Pageof 2

Frequent Collaborators

8 joint publications

Sidong Huang

6 joint publications

William D Foulkes

5 joint publications

Morag Park

3 joint publications

Leora Witkowski